ECCT is a groundbreaking treatment modality that uses low-frequency, low-intensity electrostatic fields to target and destroy cancer cells without harming healthy tissue. Developed to address cancers that are resistant to conventional treatments, ECCT offers a safe and non-invasive alternative with proven efficacy in
Electro-Capacitive Cancer Therapy (ECCT) operates by generating electric fields in the tumor region, disrupting the polarization of cancer cells during mitosis. This intervention in the cell division process leads to the self-destruction of cancer cells while preserving healthy tissue. This targeted approach minimizes side effects and enhances treatment efficacy. One of the defining characteristics of cancer cells is their uncontrolled cell division, which is highly electrically polarized and therefore sensitive to external electric fields. ECCT harnesses this sensitivity by applying electric fields to interfere with cell division and ultimately eliminate cancer cells.
ECCT consists of two primary components: the apparel, which holds the capacitive electrodes, and an oscillator that generates electric waves with specific intensity, waveform, and frequency.
The effectiveness of ECCT in cancer treatment is influenced by several factors, including the coverage provided by the apparel, the frequency, intensity, and waveform produced by the oscillator, as well as the duration of equipment usage, which determines the cancer's exposure to electrostatic waves. To achieve successful tumor elimination, the design of the apparel is crucial in the treatment process and must be tailored to the tumor's location and stage.
During normal cell division, microtubules guide chromosomes to opposite poles of the cell. However, when exposed to the electric field of ECCT, this polarization process is disrupted, resulting in mitotic arrest and subsequent cell death. This mechanism is especially effective against malignant cells with high proliferation rates, making ECCT a highly suitable therapy for aggressive cancers.
CEF can stop the growth of tumors by inhibiting cancer cell division. It may be particularly effective against cancer types that are resistant to conventional treatments like chemotherapy or radiation therapy.
Traditional treatments often damage healthy cells, leading to significant side effects. CEF selectively targets cancer cells, minimizing damage to healthy tissues and reducing side effects.
CEF does not require invasive procedures like the implantation of electrodes under the skin. This leads to less trauma for patients, and a faster recovery time.
CEF can be tailored to the genetic and biological characteristics of the tumor. This allows for a personalized treatment approach that is optimized for each individual patient.
CEF targets the electrical properties of cancer cells, which can enhance treatment precision. This allows for more effective shrinking or elimination of tumors.
CEF can be combined with other treatment methods (such as chemotherapy or radiation therapy). This integration can improve the overall effectiveness of treatment and contribute to the patient’s broader treatment process.
Telif Hakkı © 2025 OncoXAI - Tüm Hakları Saklıdır.
Web sitesi trafiğini analiz etmek ve web sitesi deneyiminizi optimize etmek amacıyla çerezler kullanıyoruz. Çerez kullanımımızı kabul ettiğinizde, verileriniz tüm diğer kullanıcı verileriyle birlikte derlenir.